Corbus Pharmaceuticals files for $300M mixed shelf offering

Surging On The Back Of Great News, But I See Dark Clouds Corbus Pharmaceuticals announces proposed public offering of common stock Corbus Pharma reverses gains on common stock offering Seeking ... Read More

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

April 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a ... Read More

Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission

is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. In addition, MIRA's novel oral ... Read More

Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced the publication of survey data describing clinician preferences among ... Read More

Monteris Medical Announces Publication of Largest Cohort to Date of LITT with NeuroBlate® System for Meningioma, Most Common Primary Brain Tumor

The company also announces forthcoming manuscript documenting 1000+ patient outcomes from LAANTERN study "My fellow investigators and I look forward to publishing a manuscript that describes the ... Read More

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

April 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings ... Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section ... Read More